miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling

Woori Kim(Harvard University), Yenarae Lee(Harvard University), Noah D. McKenna(Harvard University), Ming Yi(Science Applications International Corporation (United States)), Filip Šimunović(Harvard University), Yulei Wang, Benjamin Kong, Robert J. Rooney, Hyemyung Seo(Hanyang University), Robert M. Stephens(Science Applications International Corporation (United States)), Kai‐Christian Sonntag(Harvard University)

Neurobiology of Aging

January 24, 2014

10.1016/j.neurobiolaging.2014.01.021

Cited by 145

Abstract

Related Papers

Most mammalian mRNAs are conserved targets of microRNAs

Robin C. Friedman, Kyle Kai‐How Farh, Christopher B. Burge et al.|Genome Research|2008|8.6k

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

Romain Zufferey, Dea Nagy, Ron J. Mandel et al.|Nature Biotechnology|1997|2k

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Konrad Talbot, Hoau-Yan Wang, Hala Kazi et al.|Journal of Clinical Investigation|2012|1.8k

A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons

Jong‐Pil Kim, Keiichi Inoue, Jennifer Ishii et al.|Science|2007|1.2k

Repression of α-synuclein expression and toxicity by microRNA-7

Eunsung Junn, Kang‐Woo Lee, Byeong Seon Jeong et al.|Proceedings of the National Academy of Sciences|2009|631